نتایج جستجو برای: نمره edss

تعداد نتایج: 15968  

2014
Alice Laroni Ilaria Gandoglia Claudio Solaro Giuseppe Ribizzi Tiziana Tassinari Matteo Pizzorno Sergio Parodi Giovanna Baldassarre Maria Teresa Rilla Simonetta Venturi Elisabetta Capello Maria Pia Sormani Antonio Uccelli Giovanni Luigi Mancardi

BACKGROUND Optimal patient selection would improve the risk-benefit ratio of natalizumab treatment for relapsing-remitting multiple sclerosis (RR MS). Clinical features of subjects responding to natalizumab have not been univocally recognized. METHODS Longitudinal data on RR MS patients treated with natalizumab in Liguria, Italy are reported. Predictors of relapse occurrence and disability im...

Journal: :Journal of the Chinese Medical Association : JCMA 2016
Isil Guzel Semra Mungan Zeynep Neşe Oztekin Fikri Ak

BACKGROUND Multiple sclerosis (MS) is a chronic autoimmune demyelinating disease characterized by inflammation of white matter in the central nervous system. It has been indicated that this inflammation causes increased levels of proinflammatory cytokines. Therefore, we aimed to evaluate if there is a possible association between inflammatory markers and the Expanded Disability Status Scale (ED...

Journal: :Journal of neurology, neurosurgery, and psychiatry 2010
M B D'hooghe G Nagels B M J Uitdehaag

BACKGROUND The uncertainty about long-term effects of childbirth presents MS patients with dilemmas. METHODS Based on clinical data of 330 female MS patients, the long-term effects of childbirth were analysed, using a cross-sectional study design. Four groups of patients were distinguished: (1) without children (n = 80), (2) with children born before MS onset (n = 170), (3) with children born...

Journal: :Neurology 2011
M P Sormani D K Li P Bruzzi B Stubinski P Cornelisse S Rocak N De Stefano

OBJECTIVE In multiple sclerosis (MS), the aim of therapies is to prevent the accumulation of irreversible disability. This is difficult to assess given the short time course of clinical trials. MRI markers and relapses are often used as surrogate of disability in MS studies, but their validity remains controversial. We sought to validate, at the individual patient level, MRI lesions and relapse...

2014
Payam Sarraf Sepeher Azizi Abdorreza Naser Moghaddasi Mohammad Ali Sahraian Abbas Tafakhori Mahsa Ghajarzadeh

BACKGROUND Impaired quality of life (QOL) is an issue considered in patients with multiple sclerosis (MS). There are limited studies evaluated poor sleep and impaired QOL in these cases. The aim of this study was to evaluate quality of sleep and poor sleep in Iranian patients with MS and the relationship between Pittsburgh Sleep Quality Index (PSQI) score and QOL subscales. METHODS One-hundre...

Journal: :Frontiers in bioscience 2013
Jesper Hagemeier Bianca Weinstock-Guttman Mari Heininen-Brown Guy U Poloni Niels Bergsland Claudiu Schirda Christopher R Magnano Cheryl Kennedy Ellen Carl Michael G Dwyer Alireza Minagar Robert Zivadinov

The association between clinical outcomes and abnormal susceptibility-weighted imaging (SWI)-filtered phase, indicative of increased iron content, as well as atrophy, was investigated in the subcortical deep-gray matter (SDGM) of multiple sclerosis (MS) patients. 149 relapsing-remitting (RR) and 61 secondary-progressive (SP) MS patients underwent SWI on a 3T scanner. Mean phase of the abnormal ...

2013
R. Alroughani J. Al Hashel A. Thussu S.F. Ahmed

OBJECTIVE To evaluate the outcomes of patients with multiple sclerosis (MS) who were treated with natalizumab in Kuwait. MATERIALS AND METHODS A retrospective study using the MS registry to identify patients who were treated with natalizumab was conducted. Patients' demographics, clinical characteristics and treatment parameters were collected at baseline and last follow-up visit. Primary out...

2013
Karine Baumstarck Helmut Butzkueven Oscar Fernández Peter Flachenecker Sergio Stecchi Egemen Idiman Jean Pelletier Mohamed Boucekine Pascal Auquier

BACKGROUND Responsiveness, defined as the ability to detect a meaningful change, is a core psychometric property of an instrument measuring quality of life (QoL) rarely reported in multiple sclerosis (MS) studies. OBJECTIVE To assess the responsiveness of the Multiple Sclerosis International Quality of Life (MusiQoL) questionnaire to change in disability over 24 months, defined by change in t...

2017
Tingting Zhang Elaine Kingwell Feng Zhu John Petkau Lorne F Kastrukoff Ruth Ann Marrie Helen Tremlett Charity Evans

OBJECTIVE To examine the association between optimal adherence to the first-generation injectable immunomodulatory drugs (IMDs) for multiple sclerosis (MS) and subsequent disability accumulation. METHODS We accessed prospectively collected linked clinical and administrative health data from British Columbia, Canada. Subjects with MS treated with a first-generation injectable IMD at an MS clin...

Journal: :Multiple sclerosis 2017
Marcus D'Souza Özgür Yaldizli Roland John Deborah R Vogt Athina Papadopoulou Elisabeth Lucassen Milena Menegola Michaela Andelova Frank Dahlke Franz Schnyder Ludwig Kappos

BACKGROUND To improve the consistency of standardized Expanded Disability Status Scale (EDSS) assessments, an electronic data capture tool and analysis tool was developed, Neurostatus e-Scoring (NESC). This tool allows real-time feedback by comparing entries with established scoring rules. OBJECTIVE To test whether using NESC reduces inconsistencies as compared to the paper-and-pencil version...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید